Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botensilimab and Balstilimab Optimization in Colorectal Cancer (BBOpCo)

NCT06268015 is registered in ClinicalTrials.gov with Nicholas DeVito, MD as lead sponsor.

NCT NCT06268015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06268015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botensilimab and Balstilimab Optimization in Colorectal Cancer (BBOpCo)
Lead sponsor
Nicholas DeVito, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 18, 2024
Completion date
July 31, 2028
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer